Natco Pharma Reports 34 Drop in Q4 Net Profit Amid Revenue Decline SANA Q1 2026 Earnings Narrow EPS Beat Highlights Continued Progress in Cell Therapy Pipeline Zscaler Shares Plummet 31 After Prudent Guidance Sales Restructuring